SYDNEY, Australia, 20 September 2018 – Vitex Pharmaceuticals has been awarded Quality Manufacturer of the Year at the 2018 Complementary Medicines Australia (CMA) Industry Awards. With other 400 guests in attendance, the annual event is held to recognise and celebrate the achievements of members across the Australian industry.
The High Quality Manufacturer of the Year Award honours and celebrates the company that has made the most significant contribution to the complementary medicines industry throughout the past year. The Award measures firms based on their commitment to and production of the highest standard products, and represents the complementary medicines industry to the highest standard.
“We are incredibly proud to have won the High Quality Manufacturer of the Year Award. This recognition by our industry colleagues is a testament to our ongoing commitment to quality and we are humbled to represent Australia in the global landscape as the benchmark for pharmaceutical manufacturing excellence,” said Dr Aniss Chami, Chief Executive Officer, Vitex.
“With increasing global demand for Australian made products, it is more apparent than ever to preserve our high quality manufacturing standards throughout the industry. This industry reputation has fuelled investment into Australia and contributes to the significant growth of employment and the local economy. We continue to take this responsibility seriously because we recognise the impact our business has on our community, clients and consumers,” concluded Dr Chami.
In November 2017, the Hon Malcolm Turnbull MP, Prime Minister of Australia, officially opened Vitex’s new best-in-class A$100 million manufacturing plant which will create close to 420 jobs in western Sydney.